Invention Grant
- Patent Title: Azaindazoles
-
Application No.: US13696601Application Date: 2011-05-05
-
Publication No.: US08637509B2Publication Date: 2014-01-28
- Inventor: Joelle Lorraine Burgess , Neil Johnson , Steven D. Knight , Louis LaFrance , William H. Miller , Kenneth Newlander , Stuart Romeril , Meagan B. Rouse , Xinrong Tian , Sharad Kumar Verma , Dominic Suarez
- Applicant: Joelle Lorraine Burgess , Neil Johnson , Steven D. Knight , Louis LaFrance , William H. Miller , Kenneth Newlander , Stuart Romeril , Meagan B. Rouse , Xinrong Tian , Sharad Kumar Verma , Dominic Suarez
- Applicant Address: US PA Philadelphia
- Assignee: GlaxoSmithKline LLC
- Current Assignee: GlaxoSmithKline LLC
- Current Assignee Address: US PA Philadelphia
- Agent Duke M. Fitch; Kathryn A. Lutomski; John Lemanowicz
- International Application: PCT/US2011/035344 WO 20110505
- International Announcement: WO2012/005805 WO 20120112
- Main IPC: A61K31/444
- IPC: A61K31/444 ; A61P35/00 ; A61K31/506 ; A61K31/5377 ; A61K31/513 ; C07D471/04 ; A61K31/4545
Abstract:
Herein are disclosed azaindazoles of formula (I) where the various groups are defined herein, and which are useful for treating cancer.
Public/Granted literature
- US20130059849A1 AZAINDAZOLES Public/Granted day:2013-03-07
Information query
IPC分类:
